Navigation Links
Sudden Death Risk Highest 30 Days After Heart Attack
Date:11/4/2008

But mortality rate has declined over past 3 decades, study shows

TUESDAY, Nov. 4 (HealthDay News) -- The risk of sudden death after a heart attack has improved significantly over the past three decades, but the first 30 days remain a period of great danger, an historical study shows.

The study looked at the experiences of almost 3,000 residents of Olmsted County in Minnesota who had heart attacks between 1979 and 2005.

"There were two main aspects of the study that we did not necessarily anticipate," said Dr. Veronique Roger, a professor of medicine and epidemiology at the Mayo Clinic, and lead author of the report in the Nov. 5 issue of the Journal of the American Medical Association. "One was how much the risk of sudden death after a heart attack has decreased over time. The magnitude of decline was 40 percent over the study period. The second was that if a patient experienced heart failure at any time during the follow-up, the risk of sudden death increased substantially."

In all, 1,160 of those who had heart attacks died, 24 percent of them suffering sudden cardiac death. The incidence of sudden cardiac death was 1.2 percent in the first 30 days. It decreased sharply after that, leveling off at 1.2 percent a year, lower than the rate of sudden death in the general population.

Among heart attack survivors who experienced heart failure, the rate of sudden cardiac death was 2.5 percent in the first 30 days and in each of the following years.

The study "underscores the imperative to work together to provide the best possible care" in the weeks after a heart attack, Roger said. "We need to be particularly alert to monitor patients regularly for any sign of heart failure, to apply additional treatments, therapeutic and management options," she said.

If there are suspicions of heart failure, the progressive loss of the heart's ability to pump blood, an imaging study such as echocar
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Kidney Patients More Susceptible to Sudden Cardiac Death
2. New Research: Americans Underestimate Dangers of Sudden Cardiac Arrest
3. Sudden Rise in Allergies and Asthma After Hurricane Ike
4. Making Sudden Cardiac Arrest a National Health Priority: National Medical Association Issues White Paper on Sudden Cardiac Arrest
5. Screening Athletes Could Cut Sudden Cardiac Death Risk
6. Tim Russerts Death Provides Important Opportunity for News Media to Increase Public Awareness of How to Prevent Sudden Cardiac Arrest
7. Tim Russerts Sudden Cardiac Death May Have Been Preventable
8. Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
9. Study Offers Clues to Link Between Arrhythmia, Sudden Death
10. Health Leaders Join to Elevate Sudden Cardiac Arrest to a National Public Health Priority
11. Boston Scientific Announces First European Implants of New Devices to Treat Heart Failure and Sudden Cardiac Death

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sudden Death Risk Highest 30 Days After Heart Attack
Sudden Death Risk Highest 30 Days After Heart Attack
(Date:11/27/2009)... Holdings has announced that it has become a natio...e largest nonprofit organizations dedicated to art... Delray Beach, FL (Vocus) Nov...XCHO), a company specializing in the marketing and...ts, has announced today that is has become a natio...
(Date:11/27/2009)...ealth™ announced today that Spectrum Health ...d Enterprise orthopedic templating solution and it... (PRWEB) November 27, 2009 -- Voyant...h (Grand Rapids, Michigan) has licensed its Trauma...its TraumaCad Extend workflow solution, to allow i...
(Date:11/26/2009)...--Withcoldandfluseasonuponus,it,smoreimportantthan...tionsandavoidillness. ,, "Weneedtobeproactiveno...illnessifwe,resick,"saidEileenFinerty,RN,MS,CIC(ce...ctioncontrolandoccupationalhealthatHospitalforSpec...alSurgeryhasoneofthelowestinfectionratesofanyhospi...
(Date:11/26/2009)...y can lead to strains or worse , , THURS...ing wrong with stuffing your turkey full to bursti...th your suitcase as you pack for holiday trips. ,... U.S. hospital emergency rooms, doctors, offices, ...elated injuries, such as muscle strains, pulls and...
(Date:11/26/2009)... Triangle Dental (RTDental), a leading dental grou...ced the expansion of its services to include LUMIN...millan. , Durham, NC (...nnounce that Dr. Doug Macmillan, an experienced L...l advanced training seminar. RTDental’s abi...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...Food and Drug Administration (FDA) today announced...and Factor Complex (Human), Alphanate. //The produ...invasive procedures with von Willebrand disease (v...oing major surgery. The disease is the most common...
...m (Tamil Nadu): Over 3,000 transsexuals in Tamil N...hat society will now "see" them differently.// ...n AIDS awareness campaigner from Vellore and pledg...ervices. The mass eye donation by the 'arav...
...s have found more than 250 species of bacteria dw...animal //species in a zoo, which prompts lead rese...acteria out there on the human body. Stating t...er says he was astounded by results of his work, w...
..., a drug used for limiting blood loss in patients ...increased risk of death during five years followin...rotinin was first approved for use in high-risk pa...ion patients worldwide have received aprotinin sin...
...y published in Clinical Pediatrics, it is reported...itamin D. If this deficit is taken care of, their ...ency disorders. Joyce M. Lee and his team belo...nd to be deficient in vitamin D. Among their child...
...rs have found that wisdom in old age depends on a ...researchers found that when mature mice learn a ne...e times more active than their old ones, the New S...roup of mice with a chemical agent that stains onl...
Other Medicine News:Health News:FDA Approves New Product to Treat Von Willebrand Disease 2Health News:The Other Side of Transsexuals 2Health News:Unknown Species of Bacteria Among a ‘zoo’ of Them on the Human Bo 2Health News:Drug Used in Coronary Artery Bypass Surgery may Increase Risk of Death 2
(Date:11/25/2009)...inker.comannouncesthatanewmarketresearchreportisav...ry-USMarketTrends&Analysis http://www.reportl...arket-Trends--Analysis.html ,, TheUSintranasal...uticapplicationsfromthedeliveryofconventionallocal...drugs.Thefutureofthetechnologyhingesontotheeffecti...
(Date:11/25/2009)...re/-- ChemoCentryx,Inc.,announcedtodaythatPhaseII...ectiveRandomizedOralTherapyEvaluationinCrohn,sdise...moderate-to-severeCrohn,sdiseasedemonstratedclinic...le.Thestudydemonstratedevidenceofclinicalefficacyi...decreaseintheCrohn,sDiseaseActivityIndex(CDAI)inpa...
(Date:11/24/2009)...stCall/--Endologix,Inc.(Nasdaq: ELGX ),developerof...uncedtodaythatithasfiledamotiontostay,ordiscontinu...ghtagainstitinOctober2009byCook,Inc.Themotionwasfi...diana. ,, Endologixhasrequestedthatthestayremai...ice(USPTO)conductsproceedingstore-examinethetwopat...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 1Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 1National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 2National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 4National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 1Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 2Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 3Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 4Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 6Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 7Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 8Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 9Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 10
...linical program to evaluate PROMUS(TM) Element(TM)...3 Boston Scientific Corporation (NYSE: BSX ) to...in the PLATINUM clinical trial, which is designed ...verolimus-Eluting Coronary Stent. The first U.S. ...er of the Rockies in Loveland, Colorado by Thomas ...
...NG-WEIHENSTEPHAN, Germany, February 3 Pieris AG, ...R), a novel class of targeted,human protein therap...,progress in the development of its Anticalin(R) c...oad therapeutic applicability. , Having succes...in vitro,and in vivo, Pieris has now validated the...
Other Medicine Technology:Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 2Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 3Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 4Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 5Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist 2Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist 3
IMMULITE/IMMULITE 1000 Cortisol
...ors from KUBTEC represents a stand-alone, high-res...to 16 bit digital interface. The large sensing are... spacing down to 48 microns. All models are availa...ed energy range (10-160 kV). Applications range fr...
...UBTEC is a dual capability system with the ability...on of the specimen under test. While the XCAT seri...X-ray images, the micro focus source also allows t...ard 2D images. The 100 mm x 100 mm digital detecto...
...men radiography. The XPERT represents a research t...n every digital x-ray image, thus being able to ca...ore were lost to the human eye. With features incl...e, multi-color digital operator interface, and a 1...
Medicine Products: